Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Cisplatin (liposomal)

EU orphan designation number: EU/3/07/451   
Active ingredient: Cisplatin (liposomal)
Indication: Treatment of pancreatic cancer
Sponsor: Regulon AE
Afxentiou 7, Alimos, 17455, Athens, Ελλάδα

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/06/2007 Orphan designation EMEA/OD/103/06 (2007)2561 of 8/06/2007